AstraZeneca to Buy Alexion Pharmaceuticals for $39 Billion. What to Know
AstraZeneca said Alexion’s expertise will accelerate its growing presence in immunology. The deal is one of the year’s largest drug mergers.
Full Article
AstraZeneca to Buy Alexion Pharmaceuticals for $39 Billion. What to Know
Upworthy
0 shares
1 views
You might like
Related news coverage
AstraZeneca stock price falls sharply on a $39 billion bill to buy Alexion
Invezz
Investors don’t seem impressed with AstraZeneca’s (LON: AZN) latest deal, which is also the biggest deal in the company’s..
-
Alexion, Pluralsight rise; SolarWinds, Virgin Galactic fall
SeattlePI.com
-
News24.com | WATCH | AstraZeneca shares dip after $39 billion Alexion deal
News24
-
AstraZeneca stock tumbles as Alexion shares soar after companies agree on takeover deal
Upworthy
-
Alexion Pharmaceuticals soars 35% after AstraZeneca agrees to $39 billion takeover
Business Insider
Advertisement
More coverage
AstraZeneca to acquire Alexion Pharmaceuticals for £29.50 billion
Invezz
AstraZeneca plc (LON: AZN) said on Saturday that it will buy Alexion Pharmaceuticals (NASDAQ: ALXN) for £29.50 billion. The..
-
UK's Astrazeneca buying US Biotech firm Alexion for 39 Billion dollars to expand in immunology
Mid-Day
-
AstraZeneca Agrees To Buy Alexion Pharma In $39 Bln Cash And Stock Deal
RTTNews
-
AstraZeneca buying drug developer Alexion for $39 billion
SeattlePI.com
-
AstraZeneca to Buy Alexion Pharmaceuticals for $39 Billion
Motley Fool